Skip to main content

previous disabled Page of 4
and
  1. Chapter

    Impedance and Collective Effects

    As the beam intensity increases, the beam can no longer be considered as a collection of non-interacting single particles: in addition to the “single-particle phenomena”, “collective effects” become significan...

    E. Metral, G. Rumolo, W. Herr in Particle Physics Reference Library (2020)

  2. No Access

    Article

    Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation—a retrospective analysis on seven patients

    Refractory skin ulcers due to severe chronic graft-versus-host disease (cGVHD) remain to be associated with significant morbidity and mortality.

    P. Lamby, D. Wolff, S. Mielke, G. U. Grigoleit, P. Ljungman in Annals of Hematology (2019)

  3. Article

    Open Access

    Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine

    The aim of this randomized phase-II study was to evaluate the effect of substituting cytarabine by azacitidine in intensive induction therapy of patients with acute myeloid leukemia (AML). Patients were random...

    R. F. Schlenk, D. Weber, W. Herr, G. Wulf, H. R. Salih, H. G. Derigs in Leukemia (2019)

  4. Article

    Open Access

    Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial

    Systemic therapy for advanced hepatocellular carcinoma (HCC) is still challenging. A biomodulatory therapy approach targeting the communicative infrastructure of HCC, including metronomic low-dose chemotherapy...

    I. Walter, U. Schulz, M. Vogelhuber, K. Wiedmann, E. Endlicher in Medical Oncology (2017)

  5. No Access

    Article

    Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

    Cytomegalovirus (CMV) infection is a common, potentially life-threatening complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT). We assessed prospectively the safety and efficac...

    M Neuenhahn, J Albrecht, M Odendahl, F Schlott, G Dössinger, M Schiemann in Leukemia (2017)

  6. No Access

    Article

    HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation

    Refractory or relapsed acute myeloid leukemia (AML) represents a frequent complication after allogeneic hematopoietic stem-cell transplantation (HSCT). We show herein that primary in vitro stimulation of CD45RA-s...

    W Herr, Y Eichinger, J Beshay, A Bloetz, S Vatter, C Mirbeth, E Distler in Leukemia (2017)

  7. No Access

    Article

    Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset

    We analyzed lymphocyte subpopulations and cytokines 3 months after allogeneic hematopoietic stem cell transplantation aiming to identify predictive cellular and serum markers for chronic graft-versus-host dise...

    E.-M. Bohmann, U. Fehn, B. Holler, D. Weber, E. Holler, W. Herr in Annals of Hematology (2017)

  8. No Access

    Article

    Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation

    Intestinal dysbiosis has been associated with acute gastrointestinal GvHD and poor outcome following allogeneic stem cell transplantation (ASCT). To assess the effect of a switch in 2012 from ciprofloxacin/met...

    D Weber, P J Oefner, K Dettmer, A Hiergeist, J Koestler in Bone Marrow Transplantation (2016)

  9. Article

    Open Access

    Human genome meeting 2016

    O1 The metabolomics approach to autism: identification of biomarkers for early detection of autism spectrum disorder

    A. K. Srivastava, Y. Wang, R. Huang, C. Skinner, T. Thompson, L. Pollard in Human Genomics (2016)

  10. No Access

    Article

    Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia

    DNA methylation changes are a constant feature of acute myeloid leukemia. Hypomethylating drugs such as azacitidine are active in acute myeloid leukemia (AML) as monotherapy. Azacitidine monotherapy is not cur...

    C Müller-Tidow, P Tschanter, C Röllig, C Thiede, A Koschmieder, M Stelljes in Leukemia (2016)

  11. Article

    Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

    M. Vogelhuber, S. Feyerabend, A. Stenzl, T. Suedhoff, M. Schulze in Cancer Microenvironment (2015)

  12. Article

    Open Access

    Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

    Therapeutic options for patients with castration-resistant prostate cancer (CRPC) remain limited. In a multicenter, Phase II study, 65 patients with histologically confirmed CRPC received a biomodulatory regim...

    M. Vogelhuber, S. Feyerabend, A. Stenzl, T. Suedhoff, M. Schulze in Cancer Microenvironment (2015)

  13. No Access

    Article

    Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis

    Depletion of naive T cells from donor leukapheresis products (LPs) aims at the reduction of alloreactivity, while preserving memory T-cell reactivity (for example, to pathogens). This study established the imm...

    D Teschner, E Distler, D Wehler, M Frey, D Marandiuc in Bone Marrow Transplantation (2014)

  14. No Access

    Article

    Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantation

    Donor lymphocyte infusions (DLI) are used to resolve mixed T-cell chimerism (TCC) after allo-SCT despite a substantial risk of GVHD. We analyzed the impact of prophylactic CD8-depleted (CD8depl) DLI in 20 recipie...

    R G Meyer, E M Wagner, A Konur, K Bender, T Schmitt in Bone Marrow Transplantation (2010)

  15. No Access

    Article

    Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation

    Although thymoglobulin and alemtuzumab are frequently used in hematopoietic stem cell transplantation (HSCT), little is known of their effects on NK cells, which mediate important functions in post-transplanta...

    O Penack, L Fischer, A Stroux, C Gentilini, A Nogai in Bone Marrow Transplantation (2008)

  16. No Access

    Article

    Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation

    M Bornhauser, C Thiede, J Babatz, J Schetelig, T Illmer, A Kiani, U Platzbecker in Leukemia (2006)

  17. No Access

    Article

    Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes

    Selective depletion of alloreactive T cells from stem-cell allografts should abrogate graft-versus-host disease while preserving beneficial T cell specificities to facilitate engraftment and immune reconstitut...

    U F Hartwig, M Nonn, S Khan, R G Meyer, C Huber, W Herr in Bone Marrow Transplantation (2006)

  18. No Access

    Article

    Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not man

    Mutations and aberrant expression of the p53 tumor suppressor protein are the most frequent molecular alterations in human malignancy. Peptides derived from the wild-type (wt) p53 protein and presented by majo...

    J Kuball, M Schuler, E Antunes Ferreira, W Herr, M Neumann in Gene Therapy (2002)

  19. No Access

    Chapter and Conference Paper

    Shared and Individual CTL-Defined Antigens on Human Melanoma Cells

    Cytolytic T Iymphocytes (CTL) have been shown to mediate immune protection and rejection responses in animal tumor models. T Iymphocytes recognize not intact proteins, but protein-derived peptides presented by...

    T. Wölfel, J. Schneider, M. Hauer, C. Wölfel, W. Herr in Symposium in Immunology VI (1997)

  20. No Access

    Article

    Inclusive charged particle cross sections in full phase space from proton proton interactions at ISR energies

    Measurements are presented of inclusive charged particle production in proton-proton collisions at √s=31, 44 and 62 GeV at the CERN ISR. The large acceptance of the Split Field Magnet detector allows a single exp...

    A. Breakstone, H. B. Crawley, A. Firestone in Zeitschrift für Physik C Particles and Fie… (1995)

previous disabled Page of 4